BSE Live
Dec 04, 16:01Prev. Close
433.00
Open Price
430.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 04, 15:56Prev. Close
433.45
Open Price
430.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
428.20 (115)
| Key Financial Ratios of Thyrocare Technologies (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 17.95 | 13.44 | 10.77 | 28.75 | 22.66 | |
| Diluted EPS (Rs.) | 17.90 | 13.41 | 10.75 | 28.70 | 22.62 | |
| Cash EPS (Rs.) | 26.85 | 20.82 | 17.20 | 34.12 | 26.64 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 101.36 | 97.04 | 98.44 | 98.43 | 84.26 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 101.36 | 97.04 | 98.44 | 98.43 | 84.26 | |
| Dividend / Share(Rs.) | 21.00 | 18.00 | 18.00 | 15.00 | 25.00 | |
| Revenue from Operations/Share (Rs.) | 119.48 | 98.97 | 91.91 | 106.15 | 89.70 | |
| PBDIT/Share (Rs.) | 37.81 | 26.64 | 22.18 | 45.03 | 34.62 | |
| PBIT/Share (Rs.) | 29.03 | 19.25 | 15.74 | 39.65 | 30.63 | |
| PBT/Share (Rs.) | 28.54 | 18.55 | 15.32 | 39.20 | 30.51 | |
| Net Profit/Share (Rs.) | 18.08 | 13.44 | 10.76 | 28.74 | 22.65 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 31.64 | 26.91 | 24.13 | 42.42 | 38.58 | |
| PBIT Margin (%) | 24.29 | 19.45 | 17.12 | 37.35 | 34.14 | |
| PBT Margin (%) | 23.88 | 18.74 | 16.66 | 36.93 | 34.00 | |
| Net Profit Margin (%) | 15.12 | 13.57 | 11.71 | 27.07 | 25.25 | |
| Return on Networth / Equity (%) | 17.83 | 13.84 | 10.93 | 29.20 | 26.88 | |
| Return on Capital Employed (%) | 27.20 | 18.73 | 15.46 | 39.07 | 34.81 | |
| Return on Assets (%) | 14.16 | 11.46 | 9.31 | 25.46 | 22.69 | |
| Total Debt/Equity (X) | 0.00 | 0.04 | 0.00 | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 0.98 | 0.85 | 0.80 | 1.00 | 89.85 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 2.69 | 3.23 | 3.22 | 3.83 | 2.91 | |
| Quick Ratio (X) | 2.28 | 2.63 | 2.85 | 3.43 | 2.56 | |
| Inventory Turnover Ratio (X) | 13.85 | 4.27 | 5.85 | 6.98 | 21.40 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 133.91 | 139.28 | 52.16 | 44.11 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 86.41 | 87.14 | 43.93 | 37.51 | |
| Earnings Retention Ratio (%) | 0.00 | -33.91 | -39.28 | 47.84 | 55.89 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 13.59 | 12.86 | 56.07 | 62.49 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 3,552.40 | 3,121.37 | 2,258.01 | 4,081.14 | 4,766.23 | |
| EV/Net Operating Revenue (X) | 5.61 | 5.96 | 4.64 | 7.27 | 10.05 | |
| EV/EBITDA (X) | 17.73 | 22.13 | 19.23 | 17.13 | 26.04 | |
| MarketCap/Net Operating Revenue (X) | 5.69 | 5.98 | 4.68 | 7.29 | 10.07 | |
| Retention Ratios (%) | 0.00 | -33.91 | -39.28 | 47.83 | 55.88 | |
| Price/BV (X) | 6.71 | 6.10 | 4.37 | 7.86 | 10.72 | |
| Price/Net Operating Revenue | 5.69 | 5.98 | 4.68 | 7.29 | 10.07 | |
| Earnings Yield | 0.03 | 0.02 | 0.03 | 0.04 | 0.03 |
28.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
24.10.2025
15.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Standalone September 2025 Net Sales at Rs 202.23 crore, up 24.03% Y-o-Y
28.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Standalone September 2025 Net Sales at Rs 202.23 crore, up 24.03% Y-o-Y
24.07.2025
Thyrocare Techn Standalone June 2025 Net Sales at Rs 178.89 crore, up 24.55% Y-o-Y
06.10.2021
Thyrocare Technologies Q2 PAT may dip 2.9% YoY to Rs 41.8 cr: Prabhudas Lilladher
12.07.2019
Thyrocare Technologies Q1 PAT may dip 6.5% YoY to Rs. 22.1 cr: Prabhudas Lilladher
12.04.2019
Thyrocare Technologies Q4 PAT seen up 18.1% YoY to Rs. 29.7 cr: Prabhudas Lilladher
17.04.2018
Thyrocare Technologies Q4 PAT seen up 68.7% YoY to Rs 32 cr: Edelweiss